Institute for Comprehensive Medical Science, Fujita Health Universit, Toyoake-shi, 470-1192, Japan.
Department of Biology, University of Waterlo, Waterloo, ON, N2L 3G1, Canada.
F1000Res. 2021 Mar 10;10:196. doi: 10.12688/f1000research.51479.1. eCollection 2021.
In the spring of 2020, we and others hypothesized that T cells in COVID-19 patients may recognize identical protein fragments shared between the coronaviruses of the common cold and COVID-19 and thereby confer cross-virus immune memory. Here, we look at this issue by screening studies that, since that time, have experimentally addressed COVID-19 associated T cell specificities. Currently, the identical T cell epitope shared between COVID-19 and common cold coronaviruses most convincingly identified as immunogenic is the CD8 T cell epitope VYIGDPAQL if presented by the MHC class I allele HLA-A24:02. The HLA-A24:02 allele is found in the majority of Japanese individuals and several indigenous populations in Asia, Oceania, and the Americas. In combination with histories of common cold infections, HLA-A*24:02 may affect their protection from COVID-19.
在 2020 年春季,我们和其他人推测 COVID-19 患者体内的 T 细胞可能识别普通感冒冠状病毒和 COVID-19 冠状病毒之间共享的相同蛋白片段,从而赋予了交叉病毒免疫记忆。在这里,我们通过筛选研究来探讨这个问题,自那时以来,这些研究已经从实验上解决了与 COVID-19 相关的 T 细胞特异性问题。目前,最令人信服地确定 COVID-19 和普通感冒冠状病毒之间共享的相同 T 细胞表位是免疫原性 CD8+T 细胞表位 VYIGDPAQL,如果由 MHC Ⅰ类等位基因 HLA-A24:02 呈递。HLA-A24:02 等位基因存在于大多数日本人以及亚洲、大洋洲和美洲的几个土著人群中。结合普通感冒感染史,HLA-A*24:02 可能会影响他们对 COVID-19 的保护作用。